Blog Posts by Tag: Laboratory
XIFIN LIS Keeps Laboratories Nimble: Responding Quickly to Fluctuations in COVID-19 Testing Demand and Turnaround Times
Early in the COVID-19 pandemic, laboratories were focused on the capabilities needed to get them ramped up quickly to handle COVID-19 testing. As 2020 wore on, labs were challenged to keep up with significant fluctuations in COVID testing volume, as well as ongoing shortages in test supplies.In October 2020, the Centers for Medicare & Medicaid Services (CMS) announced that starting January 1...
Q&A Explores COVID's Impact on Lab Industry Testing Volumes and Dynamics
In a recent teleconference among XIFIN and UBS executives, XIFIN’s Chairman and CEO Lâle White and Chief Operating Officer Kyle Fetter discussed COVID-19's impact on lab industry testing volumes and dynamics.The one-hour conference revealed: Hospital volumes have come back stronger than any other sector Molecular volumes are doing well Genetic testing is continuing to increase with more...
XIFIN Innovation Drives Growth in Four Critical Business Areas During COVID-19
Despite COVID-19's industry-altering effects on diagnostic labs and healthcare in general, XIFIN innovation in 2020 drove growth in four critical business areas: digital and genomic health, remote patient monitoring and medical device, healthcare informatics oncology, and traditional laboratory markets.XIFIN also generated notable client results and provided unique insights into lab testing...
UHC Announces Designated Diagnostic Provider Requirements for Coverage
On February 24, 2021, XIFIN learned that UHC has delayed the application deadline from February 28, 2021 to March 10, 2021. The go-live date of July 1, 2021 is still in place. Additional requests to confirm how places of service 81, 11, 19, 22 are impacted has been requested from UHC. XIFIN will provide additional updates as they are received. UHC recently announced plans to implement the...
Achieving Success with Next-Generation Sequencing: AI-driven Scale Plus a Strong Reimbursement Strategy
XIFIN, Inc. and Fabric Genomics recently collaborated on a webinar designed for laboratories launching or planning to launch Next-Generation Sequencing (NGS) tests. The two primary topics of the webinar are: The use of artificial intelligence (AI) to drive scale with panel testing, including practical considerations for implementing NGS testing and selecting the right panels, and automating...
XIFIN Advanced Analytics Allows you to Build Custom Analytics: BI Expert
XIFIN Business Intelligence and Advanced Analytics provide the revenue cycle management (RCM) operational performance metrics and test-level data exploration diagnostic executives require to thrive in today’s competitive healthcare marketplace. In response to diagnostic leader’s need for accurate visualizations of operational performance, XIFIN created a suite of four Advanced Analytics solutions...
XIFIN Advanced Analytics Help Diagnostic Financial, and Billing Leaders More Easily Explore Complex RCM Data: XIFIN BI Enterprise
RCM data is complex and by its very nature, changes through the claim lifecycle, which can make analysis challenging. That is why XIFIN RPM now offers advanced analytics and visualization options, in addition to its powerful business intelligence (BI) and reporting capabilities.Executive Advanced Analytics: Question and Answer Storyboard FormatXIFIN currently offers four advanced analytics...
Bank Reconciliation Can Be Automated – Learn How
Diagnostic testing volume is at an all-time high due to the COVID-19 pandemic. As a result, it is more important than ever to automate as much of the revenue cycle management (RCM) process as possible. Adding more people to the process or more work on the existing people working the process is just not feasible and is costly. One part of RCM that often remains a manual process is bank...
- 1 of 16
- next ›